title: Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation.
abstract: The findings of our initial study demonstrate for the first time the ability to terminate induced VT/VF reliably (100% of all episodes) by a single, monophasic 230-J shock delivered by the Wearable Cardioverter-Defibrillator (WCD). Although limited by sample size, our data suggest the WCD could be used as a feasible bridge to definitive implantation of an implantable cardioverter-defibrillator in patients in whom risk stratification for sudden death is not completed.
authors.affiliation: Division of Cardiology, University Hospital, Magdeburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Auricchio
authors.forename: H
authors.initials: H
authors.lastname: Klein
authors.forename: C J
authors.initials: CJ
authors.lastname: Geller
authors.forename: S
authors.initials: S
authors.lastname: Reek
authors.forename: M S
authors.initials: MS
authors.lastname: Heilman
authors.forename: S J
authors.initials: SJ
authors.lastname: Szymkiewicz
mesh_terms: D000368:Aged; D004554:Electric Countershock / Q000295:instrumentation; D015716:Electrocardiography, Ambulatory; D005260:Female; D006323:Heart Arrest / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012306:Risk; D014693:Ventricular Fibrillation / Q000628:therapy*